ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Tea drinkers have lower glaucoma risk

Soy, cruciferous vegetables could help lower breast cancer treatment side effects

The Long-Term Benefits of Drinking Oolong Tea

Wonderful White Tea: A Drink Fit for an Emperor

Why You Should Try This Sweet-Smelling and Health-Boosting Essential Oil

Arnica: This Powerful Herb Promotes Various Kinds of Healing

Chamomile Tea: Why This Ancient Therapeutic Drink Still Stands Out Today

Get ‘Hooked’ on Cat’s Claw: The Many Benefits of This Amazonian Herb

Try Apple Cider Vinegar and Black Cumin Oil as Your Go-To Salad Dressing

Chlorophyll: How to Get This Valuable Nutrient From Your Diet

 
Print Page
Email Article

Results of Fibromyalgia Syndrome Phase II Trial Announced

  [ 329 votes ]   [ Discuss This Article ]
By ImmuneSupport Staff • www.ProHealth.com • March 17, 2000


SUMMARY: A study reports promising results using 50-IU IFN alpha lozenges as an effective treatment for fibromyalgia.

ABSTRACT:
The three-month study, involving 89 Fibromyalgia patients at four clinical sites around the United States, was designed to measure the effectiveness of low doses of orally administered interferon-alpha (IFN alpha) in relieving morning stiffness of joints, a significant problem for fibromyalgia sufferers.

The double-blinded, placebo-controlled test was the second in a series of trials that, if successful, would lead to U.S. Food & Drug Administration (FDA) approval of the new treatment regimen. Patients participating in the study were divided into three groups, and each individual was given three lozenges per day. The three lozenges given to members of the first group contained 50 international units (IU) of IFN alpha each, while the second group was given one 50 IU IFN alpha lozenge and two placebos. Members of the final group received three placebos. All three groups reported a reduction in morning stiffness, but across the entire study, the improvement was most pronounced in those taking one 50 IU lozenge of IFN alpha per day. However, the result did not reach statistical significance relative to the controls, nor did increasing the dosage to three IFN alpha lozenges per day improve the results.

All 89 participants were also given a low dose of the anti-depressant drug, amitriptyline, which they began taking one month prior to the start of the IFN alpha trial and continued throughout the three-month study. Dr. Philip C. Fox, Director of Research and Development for Amarillo Biosciences, said addition of the amitriptyline was deemed necessary so the patients would not have to tolerate a four-month period without therapy. However, he also noted that use of the amitriptyline complicated the analysis and interpretation of the study results.

"In an effort to isolate the effects of the amitriptyline on the stiffness results, we looked at the responses of patients during the first month of the study, when they were receiving only amitriptyline," said Dr. Fox. "Patients who did not worsen during the first month's treatment with amitriptyline went on to demonstrate a significant reduction in morning stiffness (p=0.0035) when they took the 50-IU IFN alpha lozenges once a day for three months compared with a placebo. However, those patients who reported worsening of their morning stiffness during the first month showed no benefit during the subsequent three months of IFN alpha treatment."

The reduction in morning stiffness found in this study was consistent with results from an earlier six-week blinded trial except this test showed a more positive response in the placebo-treated group. (Note: It is well documented in such studies that patients taking placebos tend to report at least some improvement even though they are receiving no active drug.) Interestingly, though, this "placebo effect" varied significantly from site to site. At one of the four locations, for example, 20 patients were treated and those receiving one 150 IU lozenge per day reported results consistent with one-a- day groups throughout the study. However, placebo patients at this same site noted only minimal improvement relative to those at the other sites.

Fox also said that the search for relief for fibromyalgia sufferers, estimated to number between 4 million and 7 million in the U.S. alone, is important because current therapeutic options are inadequate and no medication has been specifically approved by the FDA for treatment. Rheumatologists typically prescribe pain relievers, sleeping aids, anti-depressants and exercise for patients with the syndrome.



Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil FibroSleep™ Optimized Curcumin Longvida®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get Energized with Malic Acid & Magnesium
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Restore Youthful Cognition and Well-Being Restore Youthful Cognition and Well-Being
Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew
Live Without Anxiety or Stress Live Without Anxiety or Stress
Coenzyme Q10 - The Energy Maker Coenzyme Q10 - The Energy Maker
The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol The Most Powerful Natural Antioxidant Discovered to Date - Hydroxytyrosol

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map